CD28 SHEDDING BLOCKING AGENTS

Single domain antibodies (sdAbs) that block CD28 cleavage are provided. Dimeric agents at least two membranal CD28 binding agents are also provided, as are methods of using the sdAbs and/or dimeric agents and pharmaceutical compositions and kits comprising the sdAbs and/or dimeric agents.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LEWKOWICZ, Ayala, HAKIM, Motti, FRIDMAN-DROR, Anna, CHEN ZELTSBURG, Lilach, MANDEL, Ilana, SAPIR, Yair, SHULMAN, Avidor, BEN-MOSHE, Tehila, GABAY, Tal
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Single domain antibodies (sdAbs) that block CD28 cleavage are provided. Dimeric agents at least two membranal CD28 binding agents are also provided, as are methods of using the sdAbs and/or dimeric agents and pharmaceutical compositions and kits comprising the sdAbs and/or dimeric agents.